β-Catenin Expression Negatively Correlates with WIF1 and Predicts Poor Clinical Outcomes in Patients with Cervical Cancer

Figure 4

Kaplan-Meier 5-year disease-free survival (DFS) and 5-year overall survival (OS) curves for patients with cervical cancer. ((a) and (c)) Patients with β-catenin-positive tumors tended to have poorer DFS and OS. ((b) and (d)) Patients with WIF1-positive expression had significantly better DFS and OS than those with negative results.

(a)

(b)

(c)

(d)